HCPCS Level II code J9304 designates a 10 mg injection of pemetrexed (Pemfexy), a systemic chemotherapeutic agent used in oncology. Nationally, accurate coding for high-cost oncology drugs like pemetrexed is critical for billing transparency, payer coverage determinations, and care coordination across outpatient infusion centers and hospital outpatient departments.

This analysis covers common national payers including Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find concise benchmarks for code usage and reimbursement patterns, a summary of relevant policy considerations for drug administration billing, and the clinical context necessary to understand where J9304 fits in treatment regimens. The publication also outlines typical sites of service and operational considerations for infusion delivery.

The content is intended for administrators, billing professionals, and policy analysts seeking a national-level briefing on coding and billing practices for pemetrexed injections. Data not available in the input is noted where applicable.